Source link : https://www.newshealth.biz/health-news/a-real-regulatory-dilemma-here-what-we-heard-this-week/
“It’s a real regulatory dilemma here.” — Donald Kohn, MD, of the University of California Los Angeles, at an FDA advisory committee meeting to discuss whether the bleeding reversal agent andexanet alfa (Andexxa) should get full approval. “Less hateful, less political, and more just medical professionals talking about medical stuff.” — Nick Mark, MD, a […]
Author : News Health
Publish date : 2024-11-24 21:00:00
Copyright for syndicated content belongs to the linked Source.